Table 1 Clinical features and 18F-FDG PET/CT findings of spinal intermediate bone tumors.
From: 18F-FDG PET/CT findings of intermediate bone tumors of the spine
Parameters | GCTB (N = 22) | Osteoblastoma (N = 11) | LCH (N = 10) | Epithelioid hemangioma (N = 6) | p |
|---|---|---|---|---|---|
Age | 36.3 ± 11.5 | 14.0 [10.0, 23.0] | 26.0 [19.0, 39.0] | 29.0 [31.0, 59.0] | 0.006 |
Gender | |||||
Man | 15 (68.2%) | 7 (63.6%) | 6 (60.0%) | 4 (66.7%) | 0.976 |
Woman | 7 (31.8%) | 4 (36.4%) | 4 (40.0%) | 2 (33.3%) | |
Location | |||||
Cervical vertebra | 4 (18.2%) | 5 (45.4%) | 4 (40.0%) | 0 (0.0%) | 0.215 |
Thoracic vertebra | 8 (36.4%) | 1 (9.1%) | 4 (40.0%) | 5 (83.3%) | |
Lumbar vertebra | 1 (4.5%) | 3 (27.3%) | 2 (20.0%) | 1 (16.7%) | |
Sacral vertebrae | 9 (40.9%) | 2 (18.2%) | 0 (0.0%) | 0 (0.0%) | |
Epicenter of the lesion | |||||
Vertebral body | 16 (72.7%) | 2 (18.2%) | 9 (90.0%) | 4 (66.7%) | 0.002 |
Posterior elements | 6 (27.3%) | 9 (81.8%) | 1 (10.0%) | 2 (33.3%) | |
Maximum diameter | 5.5 ± 1.6 | 2.4 ± 0.9 | 2.5 ± 0.7 | 3.4 ± 0.6 | < 0.001 |
Cortical integrity | |||||
Yes | 4 (18.2%) | 7 (63.6%) | 3 (30.0%) | 0 (0.0%) | 0.014 |
No | 18 (81.8%) | 4 (36.4%) | 7 (70.0%) | 6 (100.0%) | |
Sclerotic rim | |||||
Yes | 7 (31.8%) | 8 (72.7%) | 6 (60.0%) | 0 (0.0%) | 0.010 |
No | 15 (68.2%) | 3 (27.3%) | 4 (40.0%) | 6 (60.0%) | |
Eccentric expansile osteolysis | |||||
Yes | 18 (81.8%) | 10 (90.9%) | 9 (90.0%) | 6 (100.%) | 0.656 |
No | 4 (18.2%) | 1 (9.1%) | 1 (10.0%) | 0 (0.0%) | |
Residual bone crest/trabeculae or cacification | |||||
Yes | 18 (81.8%) | 9 (81.8%) | 6 (60.0%) | 6 (100.0%) | 0.172 |
No | 4 (18.2%) | 2 (18.2%) | 4 (40.0%) | 0 (0.0%) | |
Vertebral compression | |||||
Yes | 14 (63.6%) | 0 (0.0%) | 2 (20.0%) | 4 (66.7%) | < 0.001 |
No | 8 (36.4%) | 11 (100.0%) | 8 (80.0%) | 2 (33.3%) | |
Soft tissue mass | |||||
Yes | 21 (95.5%) | 11 (100.0%) | 10 (100.0%) | 6 (100.0%) | 0.756 |
No | 1 (4.5%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
SUVmax | 10.9 ± 4.5 | 6.7 ± 2.4 | 7.9 ± 3.6 | 8.4 ± 1.6 | 0.008 |
